ADAMTS4特异性MR肽探针对小鼠模型动脉粥样硬化斑块负荷的评估
研究在动脉粥样硬化小鼠模型中评估Gd基ADAMTS4特异性MR探针,高脂饮食4个月组注射后对比噪声比由2.25升至11.47(P<0.001),ADAMTS4免疫荧光含量与对比噪声比升高强相关(R2=0.69),普伐他汀组ADAMTS4表达降低,提示该探针是有前景的斑块特征评估方法。
要点
- ADAMTS4特异性Gd探针注射后斑块对比噪声比升高,4个月组由2.25升至11.47(P<0.001)。
- ADAMTS4免疫荧光含量与对比噪声比升高强相关(R2=0.69)。
- 普伐他汀组ADAMTS4表达降低。
核心结论
- 使用ADAMTS4特异性探针的磁共振成像是有前景的动脉粥样硬化斑块特征评估方法,可能改善动脉粥样硬化诊断和治疗中的斑块评估。
研究设计与样本
- 动物实验:雄性载脂蛋白E缺陷小鼠高脂饮食2个月(n=11)或4个月(n=11),另设高脂饮食同时饮水给予普伐他汀4个月组(n=11),对照组为标准饲料C57BL/6J小鼠(n=10)。
关键影像表现/征象
- 注射Gd基ADAMTS4特异性探针后行分子磁共振成像,随后对主动脉弓、头臂动脉和颈动脉进行离体分析。
- 随动脉粥样硬化进展,静脉注射探针后对比噪声比显著升高,4个月组注射前均值2.25、注射后均值11.47(P<0.001)。
- 激光烧蚀-电感耦合等离子体质谱证实ADAMTS4阳性区域与Gd强共定位。
诊断标准与关键数值
- 以P值<0.05为差异有统计学意义。
- 免疫荧光染色测得的ADAMTS4含量与对比噪声比升高强相关(R2=0.69)。
- 显微切割分析显示斑块区ADAMTS4基因表达显著高于对照小鼠动脉壁(P<0.001)。
临床应用与阅片要点
- 作者认为,使用ADAMTS4特异性探针的磁共振成像是有前景的斑块特征评估方法,可能改善动脉粥样硬化诊断和治疗中的斑块评估。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Atherosclerosis is the underlying cause of multiple cardiovascular pathologies. The present-day clinical imaging modalities do not offer sufficient information on plaque composition or rupture risk. A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) is a strongly upregulated proteoglycan-cleaving enzyme that is specific to cardiovascular diseases, inter alia, atherosclerosis.
MATERIALS AND METHODS: Male apolipoprotein E-deficient mice received a high-fat diet for 2 (n = 11) or 4 months (n = 11). Additionally, a group (n = 11) receiving pravastatin by drinking water for 4 months alongside the high-fat diet was examined. The control group (n = 10) consisted of C57BL/6J mice on standard chow. Molecular magnetic resonance imaging was performed prior to and after administration of the gadolinium (Gd)-based ADAMTS4-specific probe, followed by ex vivo analyses of the aortic arch, brachiocephalic arteries, and carotid arteries. A P value <0.05 was considered to indicate a statistically significant difference.
RESULTS: With advancing atherosclerosis, a significant increase in the contrast-to-noise ratio was measured after intravenous application of the probe (mean precontrast = 2.25; mean postcontrast = 11.47, P < 0.001 in the 4-month group). The pravastatin group presented decreased ADAMTS4 expression. A strong correlation between ADAMTS4 content measured via immunofluorescence staining and an increase in the contrast-to-noise ratio was detected ( R2 = 0.69). Microdissection analysis revealed that ADAMTS4 gene expression in the plaque area was significantly greater than that in the arterial wall of a control mouse ( P < 0.001). Laser ablation-inductively coupled plasma-mass spectrometry confirmed strong colocalization of areas positive for ADAMTS4 and Gd.
CONCLUSIONS: Magnetic resonance imaging using an ADAMTS4-specific agent is a promising method for characterizing atherosclerotic plaques and could improve plaque assessment in the diagnosis and treatment of atherosclerosis.
引用
- Mangarova DB, Kaufmann JO, Brangsch J, et al. ADAMTS4-Specific MR Peptide Probe for the Assessment of Atherosclerotic Plaque Burden in a Mouse Model. Invest Radiol. 2025. PMID: 39804796. doi:10.1097/RLI.0000000000001152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。